We sought to evaluate the mortality, risk factors for mortality, and resource utilization following cardiac interventions in trisomy 13 (T13) and 18 (T18) children. All T13 and T18 children who underwent a cardiac intervention from January 1999 to March 2015 were identified from the Pediatric Health Information System database. Data collected included demographics, type of congenital heart disease (CHD), cardiac interventions, comorbidities, length of stay (LOS), hospital charges, and deaths (within 30 days). Logistic regression analysis was used to determine factors associated with mortality. There were 49 (47% females) T13 and 140 (67% females) T18 subjects. The two cohorts were similar in distribution for race, geographic region, insurance type, and median household income. The most common CHD in both groups was a shunt lesion followed by conotruncal defects. Compared to T18, the T13 cohort had higher mortality (29% vs. 12%), tracheostomies (12% vs. 4%), gastrostomies (18% vs. 6%), and overall resource use (P < 0.05 for all). White race (OR 0.23, 95% CI 0.06–0.81) in T13 and older age (in weeks) at surgery in T18 (OR 0.75, 95% CI 0.64–0.86) were associated with lower mortality. A select group of T13 and T18 CHD patients can undergo successful cardiac interventions, albeit with a higher mortality and resource use. T13 patients have higher mortality and resource use compared to T18. In T13 and T18 patients, interventions for CHD may be an acceptable and ethical option following a careful individualized selection and counseling by a team of experts.
This is a preview of subscription content, log in to check access.
No funding was received for this study.
Compliance with Ethical Standards
Conflict of Interest
Dr. John C. Carey is a medical adviser for the Support Organization for Trisomy 18, 13, and Related Disorders (SOFT organization). All other authors declare that they have no conflicts of interest.
Ethical Approval and Informed Consent
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.
Rasmussen SA, Wong L-YC, Yang Q, May KM, Friedman JM (2003) Population-based analyses of mortality in trisomy 13 and trisomy 18. Pediatrics 111(4):777–784CrossRefPubMedGoogle Scholar
Baty B, Blackburn B, Carey J (1994) Natural history trisomy 18 and trisomy 13: growth, physical assessment, medical histories, survival, and recurrence risk. Am J Med Genet 49:175–188CrossRefPubMedGoogle Scholar
Nelson KE, Rosella LC, Mahant S, Guttmann A (2016) Survival and surgical interventions for children with trisomy 13 and 18. J Am Med Assoc 316(4):420–428CrossRefGoogle Scholar
Meyer RE, Liu G, Gilboa SM et al (2016) Survival of children with trisomy 13 and trisomy 18: a multi-state population-based study. Am J Med Genet Part A 170(4):825–837CrossRefGoogle Scholar
Kosho T, Nakamura T, Kawame H, Baba A, Tamura M, Fukushima Y (2006) Neonatal management of trisomy 18: Clinical details of 24 patients receiving intensive treatment. Am J Med Genet 140(9):937–944CrossRefPubMedGoogle Scholar
Baty BJ, Jorde LB, Blackburn BL, Carey JC (1994) Natural history of trisomy 18 and trisomy 13: 11. Psychomotor Development. Am J Med Genet 49:189–194CrossRefPubMedGoogle Scholar
Bruns DA (2015) Developmental status of 22 children with trisomy 18 and eight children with trisomy 13: implications and recommendations. Am J Med Genet Part A 167(8):1807–1815CrossRefGoogle Scholar
Kosho T (2008) Care of children with trisomy 18 in Japan. Am J Med Genet Part A 146:1369–1371CrossRefGoogle Scholar
Mcgraw MP, Perlman JM (2008) Attitudes of neonatologists toward delivery room management of confirmed trisomy 18: potential factors influencing a changing dynamic what’s known on this subject. Pediatrics 121:1106–1110CrossRefPubMedGoogle Scholar
Kobayashi J, Kaneko Y, Yamamoto Y, Yoda H, Tsuchiya K (2010) Radical surgery for a ventricular septal defect associated with trisomy 18. Gen Thorac Cardiovasc Surg 58(5):223–227CrossRefPubMedGoogle Scholar
Kosiv KA, Gossett JM, Bai S, Collins RT (2017) Congenital heart surgery on in-hospital mortality in trisomy 13 and 18. Pediatrics 140(5):e20170772CrossRefPubMedGoogle Scholar
Graham EM, Bradley SM, Shirali GS, Hills CB, Atz AM (2004) Effectiveness of cardiac surgery in trisomies 13 and 18 (from the Pediatric Cardiac Care Consortium). Am J Cardiol 93(6):801–803CrossRefPubMedGoogle Scholar
Costello JP, Weiderhold A, Clauden L et al (2015) A contemporary, single-institutional experience of surgical versus expectant management of congenital heart disease in trisomy 13 and 18 patients. Pediatr Cardiol 36:987–992CrossRefPubMedGoogle Scholar
Maeda J, Yamagishi H, Furutani Y et al (2011) The impact of cardiac surgery in patients with trisomy 18 and trisomy 13 in Japan. Am J Med Genet 155:2641–2646CrossRefGoogle Scholar
Muneuchi J, Yamamoto J, Takahashi Y et al (2011) Outcomes of cardiac surgery in trisomy 18 patients. Cardiol Young 21:209–215CrossRefPubMedGoogle Scholar
Kaneko Y, Kobayashi J, Yamamoto Y et al (2008) Intensive cardiac management in patients with trisomy 13 or trisomy 18. Am J Med Genet Part A 146:1372–1380CrossRefGoogle Scholar
Josephsen JB, Armbrecht ES, Braddock SR, Cibulskis CC (2016) Procedures in the 1st year of life for children with trisomy 13 and trisomy 18, a 25-year, single-center review. Am J Med Genet Part C 172:264–271CrossRefPubMedGoogle Scholar
Donovan JH, Krigbaum G, Bruns DA (2016) Medical interventions and survival by gender of children with trisomy 18. Am J Med Genet Part C172:272–278CrossRefPubMedGoogle Scholar
Kaneko Y, Kobayashi J, Achiwa I et al (2009) Cardiac surgery in patients with trisomy 18. Pediatr Cardiol 30:729–734CrossRefPubMedGoogle Scholar
Yates A, Hoffman T, Shepherd E, Boettner B, McBride K (2011) Pediatric subspecialist controversies in the treatment of congenital heart disease in trisomy 13 or trisomy 18. J Genet Couns 20:495–509CrossRefPubMedGoogle Scholar
Feudtner C, Hays RM, Haynes G, Geyer JR, Neff JM, Koepsell TD (2001) Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services. Pediatrics 107(6):e99–e99CrossRefPubMedGoogle Scholar
Peterson JK, Kochilas LK, Catton KG, Moller JH, Setty SP (2017) Long-term outcomes of children with trisomy 13 and 18 after congenital heart disease interventions. Ann Thorac Surg 103(6):1941–1949CrossRefPubMedPubMedCentralGoogle Scholar
Nelson K, Hexem K, Feudtner C (2012) Inpatient hospital care of children with trisomy 13 and trisomy 18 in the United States. Pediatrics 128(5):869–876CrossRefGoogle Scholar
Musewe NN, Alexander DJ, Teshima I, Smallhorn JF, Freedom RM (1990) Echocardiographic evaluation of the spectrum of cardiac anomalies associated with trisomy 13 and trisomy 18. J Am Coll Cardiol 15(3):673–677CrossRefPubMedGoogle Scholar
Vendola C, Canfield M, Daiger SP et al (2010) Survival of Texas infants born with trisomies 21, 18, and 13. Am J Med Genet Part A 152(2):360–366CrossRefGoogle Scholar
Jacobs JP, Mayer JE, Mavroudis C et al (2017) The Society of Thoracic Surgeons congenital heart surgery database: 2017 update on outcomes and quality. Ann Thorac Surg 103(3):699–709CrossRefPubMedGoogle Scholar
Pasquali SK, He X, Jacobs ML et al (2014) Excess costs associated with complications and prolonged length of stay after congenital heart surgery. Ann Thorac Surg 98(5):1660–1666CrossRefPubMedPubMedCentralGoogle Scholar
Dereddy NR, Pivnick EK, Upadhyay K, Dhanireddy R, Talati AJ (2017) Neonatal hospital course and outcomes of live-born infants with trisomy 18 at two tertiary care centers in the United States. Am J Perinatol 34(3):270–275PubMedGoogle Scholar
Carey JC (2010) Trisomy 18 and trisomy 13 syndromes. In: Management of genetic syndromes. 3rd Ed. pp 807–823Google Scholar
Janvier A, Farlow B, Barrington KJ (2016) Parental hopes, interventions, and survival of neonates with trisomy 13 and trisomy 18. Am J Med Genet Part C Semin Med Genet 172(3):279–287CrossRefPubMedGoogle Scholar
Bruns DA, Martinez A (2016) An analysis of cardiac defects and surgical interventions in 84 cases with full trisomy 18. Am J Med Genet Part A 170(2):337–343CrossRefGoogle Scholar
Kosho T, Kuniba H, Tanikawa Y, Hashimoto Y, Sakurai H (2013) Natural history and parental experience of children with trisomy 18 based on a questionnaire given to a Japanese trisomy 18 parental support group. Am J Med Genet Part A 161(7):1531–1542CrossRefGoogle Scholar
Andrews SE, Downey AG, Showalter DS et al (2016) Shared decision making and the pathways approach in the prenatal and postnatal management of the trisomy 13 and trisomy 18 syndromes. Am J Med Genet Part C Semin Med Genet 172(3):257–263CrossRefPubMedGoogle Scholar